UBE2T promoted the proliferation of renal cell carcinoma cells by regulating P13K/AKT signaling, suggesting that it might be a novel target for the treatment of patients with renal cell carcinoma [240]. This evidence concerns the gene AKT1 and renal cell carcinoma.